NASDAQ:VRAY Viewray Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Viewray Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.47 -0.03 (-0.86 %) (As of 10/1/2020 12:00 AM ET) Add Compare Share Today's Range$3.35Now: $3.47▼$3.5250-Day Range$2.54MA: $2.97▼$3.3152-Week Range$1.11Now: $3.47▼$4.88Volume846,220 shsAverage Volume1.84 million shsMarket Capitalization$513.37 millionP/E RatioN/ADividend YieldN/ABeta0.78 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media ViewRay, Inc. designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company's software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered. MRIdian delivers radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian provides real-time imaging that defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. MRIdian allows physicians to record the level of radiation exposure that the tumor has received and adapt the prescription between fractions as needed.Read More Beat the Market (BTM) Rank™ 3.2 Analyst's Opinion Consensus RatingViewray has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 4 buy ratings, 3 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.50, Viewray has a forecasted upside of 29.7% from its current price of $3.47.Amount of Analyst CoverageViewray has received no research coverage in the past 90 days. Previous Next 2.8 Community Rank Outperform VotesViewray has received 275 “outperform” votes. (Add your “outperform” vote.)Underperform VotesViewray has received 221 “underperform” votes. (Add your “underperform” vote.)Community SentimentViewray has received 55.44% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Viewray and other stocks. Vote “Outperform” if you believe VRAY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VRAY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldViewray does not currently pay a dividend.Dividend GrowthViewray does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Viewray insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.00% of the stock of Viewray is held by insiders.Percentage Held by Institutions83.03% of the stock of Viewray is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Viewray are expected to grow in the coming year, from ($0.72) to ($0.67) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Viewray is -3.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Viewray is -3.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioViewray has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.2Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.52 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:VRAY Previous Symbol CUSIPN/A CIK1597313 Webwww.viewray.com Phone440-703-3210Debt Debt-to-Equity Ratio0.26 Current Ratio3.90 Quick Ratio3.19Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$87.78 million Price / Sales5.85 Cash FlowN/A Price / Cash FlowN/A Book Value$1.47 per share Price / Book2.36Profitability EPS (Most Recent Fiscal Year)($1.18) Net Income$-120,200,000.00 Net Margins-166.74% Return on Equity-63.41% Return on Assets-36.34%Miscellaneous EmployeesN/A Outstanding Shares147,945,000Market Cap$513.37 million Next Earnings Date11/10/2020 (Estimated) OptionableOptionable $3.47 -0.03 (-0.86 %) (As of 10/1/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive VRAY News and Ratings via Email Sign-up to receive the latest news and ratings for VRAY and its competitors with MarketBeat's FREE daily newsletter. Viewray (NASDAQ:VRAY) Frequently Asked Questions How has Viewray's stock price been impacted by COVID-19? Viewray's stock was trading at $1.69 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VRAY shares have increased by 105.3% and is now trading at $3.47. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Viewray? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viewray in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Viewray. When is Viewray's next earnings date? Viewray is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. View our earnings forecast for Viewray. How were Viewray's earnings last quarter? Viewray Inc (NASDAQ:VRAY) announced its earnings results on Thursday, July, 30th. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.16) by $0.02. The business earned $14.22 million during the quarter, compared to analysts' expectations of $5.81 million. Viewray had a negative net margin of 166.74% and a negative return on equity of 63.41%. View Viewray's earnings history. What price target have analysts set for VRAY? 8 Wall Street analysts have issued 1 year price targets for Viewray's stock. Their forecasts range from $2.00 to $8.00. On average, they expect Viewray's share price to reach $4.50 in the next twelve months. This suggests a possible upside of 29.7% from the stock's current price. View analysts' price targets for Viewray. Who are some of Viewray's key competitors? Some companies that are related to Viewray include InMode (INMD), BioLife Solutions (BLFS), Zynex (ZYXI), Natus Medical (NTUS), AxoGen (AXGN), TransMedics Group (TMDX), Semler Scientific (SMLR), Cutera (CUTR), Stereotaxis (STXS), Soleno Therapeutics (SLNO), BioSig Technologies (BSGM), Fonar (FONR), Edap Tms (EDAP), Electromed (ELMD) and electroCore (ECOR). View all competitors. What other stocks do shareholders of Viewray own? Based on aggregate information from My MarketBeat watchlists, some companies that other Viewray investors own include Alibaba Group (BABA), Amarin (AMRN), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Verastem (VSTM), Corbus Pharmaceuticals (CRBP), Viking Therapeutics (VKTX), AbbVie (ABBV), Accuray (ARAY) and Opko Health (OPK). When did Viewray IPO? (VRAY) raised $52 million in an initial public offering (IPO) on the week of April 6th 2015. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers. What is Viewray's stock symbol? Viewray trades on the NASDAQ under the ticker symbol "VRAY." How do I buy shares of Viewray? Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Viewray's stock price today? One share of VRAY stock can currently be purchased for approximately $3.47. How big of a company is Viewray? Viewray has a market capitalization of $513.37 million and generates $87.78 million in revenue each year. The company earns $-120,200,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis. What is Viewray's official website? The official website for Viewray is www.viewray.com. How can I contact Viewray? Viewray's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at 440-703-3210 or via email at [email protected] This page was last updated on 10/1/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
